【レポートの概要（一部）】
1. Report Overview
1.1 Pharma Contract Sales Overview
1.2 Why You Should Read This Report
1.3 How this Report Delivers
1.4 Main Questions Answered by this Report
1.5 Who is this Report for?
1.6 Research and Analysis Methods
1.7 Frequently Asked Questions (FAQ)
1.8 Some Associated Reports
1.9 About Visiongain
2. Introduction to and Definition of the Pharma Contract Sales Market
2.1 Defining the Market
2.2 What is a CSO?
2.3 What Services do CSOs Provide?
2.4 The Different Marketing Channels Employed by Pharma Companies in 2016
2.5 Growing Trend of Outsourcing in the Overall Pharma Industry
2.6 The Rise in Pharma Contract Sales
2.7 Detailing: Becoming Less Relevant or is it as Important as Ever?
2.7.1 Declining Access to Doctors: Trend Continues in 2016
2.8 Large Cuts in Sales Force in Various Companies
2.9 Companies Cannot Rely Solely Upon Detailing
2.9.1 Trends Driving the Need for New Sales Models
3. Global Pharma Contract Sales Market 2016-2026
3.1 The Market in 2015
3.2 Global Pharma Contract Sales Market 2010-2015
3.2.1 Decent Growth in Past Six Years
3.3 Global Pharma Contract Sales Market 2016-2026
3.4 The Factors that will Drive Growth in this Market: Advantages of Outsourcing Pharma Sales
3.4.1 Cost and Flexibility
3.4.2 New Technologies and Sales Models
3.4.3 Emerging Markets and Mature Brands
3.4.4 Biosimilars
3.4.5 Account Management, Medical Education and Patient Support Services
3.4.6 Market Access Complexities Provide its Own Opportunities for CSOs
3.4.7 New Drug Launches
3.4.8 Summary
3.5 The Factors that will Restrain Growth in this Market: Disadvantages of Outsourcing Pharma Sales
3.6 Leading Therapeutic Submarkets for Pharma Contract Sales, Forecast 2016-2026
3.7 How Will the Therapeutic Composition of the Market Change Between now and 2026?
3.8 Contract Sales for Cardiovascular Drugs
3.8.1 Current Status
3.8.2 Recent Cardiovascular Drug Patent Expiries and FDA Approvals
3.8.3 Cardiovascular and Cerebrovascular Conditions are the World’s Most Fatal Diseases
3.8.4 Contract Sales for Cardiovascular Drugs: Submarket Forecast 2016-2026
3.9 Contract Sales for Metabolic Disorder Drugs
3.9.1 Current Status
3.9.2 430 Million People Expected to be Diagnosed with Diabetes by 2030
3.9.3 Contract Sales for Metabolic Disorders: Submarket Forecast 2016-2026
3.10 Contract Sales for Oncology Drugs
3.10.1 Current Status
3.10.2 Patent Expiries and Recent Approvals
3.10.3 Contract Sales for Oncology Drugs Forecast 2016-2026
4. Leading Service Sectors of the Pharma Contract Sales Market 2016-2026
4.1 The Leading Services
4.1.1 Leading Service Sectors of the Market, Forecast 2016-2026
4.1.2 How Will the Service Composition over the Market Change over the Next Ten Years?
4.2 Contract Detailing Submarket
4.2.1 Are we in the Midst of a Turnaround in Sales Rep Numbers in the Overall Pharma Industry?
4.2.2 What are the Trends in Sales Reps Employed by CSOs?
4.2.3 Detailing Services Offered by CSOs
4.2.4 CSOs will be Impacted by Declining Physician Access as Much as In-House Reps
4.2.5 Contract Detailing Submarket Forecast 2016-2026
4.2.6 Drivers and Restraints for this Dominant Service Submarket
4.3 Contract Non-Personal Promotion
4.3.1 The Benefits for both Pharma Companies and Doctors
4.3.2 Contract Non-Personal Promotion Submarket Forecast 2016-2026
4.3.3 Drivers and Restraints for Contract Non-Personal Promotion: Multichannel Marketing in the 21st Century
4.3.4 Further Sub-Sectors Within the Contract Non-Personal Promotion Submarket: Teledetailing and EDetailing
4.3.4.1 Contract Teledetailing Submarket: Current Status
4.3.4.2 Contract Teledetailing Submarket Forecast 2016-2026
4.3.4.3 Drivers and Restraints for Outsourced Teledetailing
4.3.4.4 Contract eDetailing Current Status
4.3.4.5 Contract eDetailing Submarket Forecast 2016-2026
4.3.4.6 Drivers and Restraints for Outsourced eDetailing
4.4 Medical Education Services Submarket Current Status
4.4.1 Medical Education Services Submarket Forecast 2016-2026
4.4.2 Medical Education Services Drivers and Restraints
4.5 Sample Management Services Submarket: Current Status
4.5.1 Sample Management Services Submarket Forecast 2016-2026
4.5.2 Drivers and Restraints for the Sample Management Services Submarket
4.5.3 J. Knipper and Company Inc: A US Leader in Sample Management Services
4.5.3.1 Company Acquires Sample Management Divisions from Leading CSOs 2010-2014
4.5.3.2 Construction Underway for New State of the Art Distribution Centre
4.5.3.3 New Multi-Million Dollar Contact Centre Opened
4.5.3.4 New Technologies to Drive Growth Over Next Ten Years
5. Leading National Markets for Pharma Contract Sales: Regulatory and Commercial Outlook 2016-2026
5.1 Current Leading National Markets
5.2 Leading Regional Markets Forecast 2016-2026
5.3 How will the Regional Composition of the Market Change between now and 2026?
5.4 Pharma Sales Regulatory Developments
5.4.1 Physician Payment Legislation in the US, Europe and Japan
5.4.1.1 The Physician Payment Sunshine Act (PPSA)
5.4.1.2 Proposed Bill to Close a Large Loophole in the PPSA, Could Come into Effect in 2017
5.4.1.3 Physician Payments in France: Increased Scrutiny
5.4.2 Domestic and International Concerns over Bribery: Recent Legislation in the US and UK
5.4.2.1 Promotional Products in the EU: New Rules
5.4.3 New Market Access Requirements in EU5 Countries
5.4.3.1 AMNOG: Stricter Pricing for Drugs in Germany
5.4.3.2 AMNOG: Has Reduced Prices of Top Sellers by 23%
5.4.3.3 Healthcare Reform in France: Pricing and Reimbursements have been set to Change for a While, is 2016 the Year it Finally Happens?
5.4.3.4 PCTs Replaced by CCGs in the UK
5.4.3.5 Pricing in the UK: Contentious Issue
5.4.4 Overtime for Sales Reps in the US: Rule Clarifications
5.5 US Pharma Contract Sales Market
5.5.1 Has Come a Long Way
5.5.2 Pharma Sales Regulation in the US
5.5.3 Trends in 2015 as Witnessed by a Large CSO
5.5.4 US Pharma Contract Sales Market Forecast 2016-2026
5.6 EU5 Pharma Contract Sales Market
5.6.1 Regulating Pharma Sales in the EU
5.6.2 Overall EU5 Pharma Contract Sales Market Forecast 2016-2026
5.6.3 UK Pharma Contract Sales Market Forecast 2016-2026
5.6.4 German Pharma Contract Sales Market Forecast 2016-2026
5.6.5 French Pharma Contract Sales Market Forecast 2016-2026
5.6.6 Italian Pharma Contract Sales Market Forecast 2016-2026
5.6.7 Spanish Pharma Contract Sales Market Forecast 2016-2026
5.7 Japanese Pharma Contract Sales Market
5.7.1 Regulation
5.7.2 Trends in 2015 as Witnessed by a Large CSO
5.7.3 Current Market Landscape
5.7.4 Japanese Pharma Contract Sales Market Forecast 2016-2026
6. Leading Emerging Markets for Pharma Contract Sales: Regulatory and Commercial Outlook 2016-2026
6.1 Pharma Contract Sales in Leading Emerging Markets in 2015
6.2 BRIC Pharma Contract Sales Markets Forecast 2016-2026
6.3 Chinese Pharma Contract Sales Market
6.3.1 Current Pharma Contract Sales Landscape in China
6.3.2 Rising In-House and Outsourced Sales Numbers
6.3.3 Concerns over Bribery
6.3.4 Chinese Pharma Contract Sales Market Forecast 2016-2026
6.4 Indian Pharma Contract Sales Market
6.4.1 Current Pharma Contract Landscape in India
6.4.2 Government and Regulatory Guidelines for Interactions Between Healthcare Professionals and Pharma Companies
6.4.3 Indian Pharma Contract Sales Market Forecast 2016-2026
6.5 Brazilian Pharma Contract Sales Market
6.5.1 Current Pharma Contract Sales Landscape in Brazil
6.5.2 State Payment Rules and Online Marketing Rules for Prescription Drugs
6.5.3 Brazilian Pharma Contract Sales Market Forecast 2016-2026
6.6 Russian Pharma Contract Sales Market
6.6.1 Current Pharma Contract Sales Landscape in Russia
6.6.2 New State Procurement Rules for Drugs Introduced in 2013
6.6.3 Tougher Rules on Interactions Between Doctors and Sales Reps in Russia
6.6.4 Russian Pharma Contract Sales Market Forecast 2016-2026
7. Pharma Contract Sales: Industry and Market Trends 2016-2026
7.1 Strengths and Weaknesses for the Global Pharma Contract Sales Market 2016-2026
7.2 Opportunities and Threats for the Global Pharma Contract Sales Market 2016-2026
7.3 Pharma Contract Sales Market: STEP Analysis 2016-2026
7.3.1 Social Factors Affecting Pharma Contract Sales to 2026
7.3.1.1 The Role of Ethics in Pharma Sales
7.4 Technological Developments to Improve Sales Strategies
7.4.1 Advantages of Using Tablets and Smartphones for Detailing
7.4.1.1 CSOs Need to Maximise on the Benefits of New Technologies
7.4.2 Closed Loop Marketing (CLM)
7.4.3 Customer Relationship Management (CRM)
7.4.4 The Advantages of Cloud Computing in Pharma Contract Sales
7.4.5 Does Big Data Have a Role in Pharma Sales?
7.4.6 Social Media in Relation to Pharma Sales
7.4.6.1 FDA Releases Long-Awaited Guidance on the use of Social Media
7.4.6.2 Pharma Industry is not Using Social Media to its Full Potential, but it Offers many Benefits
7.5 Economic Pressures are Limiting Healthcare and Marketing Budgets
7.6 Political Issues: Stricter Regulations for Pharma Sales around the World
7.7 Trends in Pharma Contract Sales 2016-2026
7.7.1 Cuts to In-House Sales Staff will Continue 2016-2026
7.7.2 There will be in an Increase in Strategic Partnering in Order to Provide Long-Term Revenue Growth
7.7.3 Leading CSOs have Consolidated, and will Continue to Consolidate, in Order to Increase Market Penetration
7.7.4 CSOs and Pharma Clients Alike Need to Stay Vigilant about the Risks of Outsourcing Pharma Sales
7.8 Drug Development Trends Affecting Pharma Sales 2016-2026
7.8.1 How will Orphan Drug Diseases Influence Pharma Contract Sales?
7.8.2 Promotion for Biosimilar Drugs over the Next Ten Years
7.8.3 There will be Greater Demand for Specialty Medicines
7.8.4 Emerging National Markets are Becoming Increasingly Important
7.9 Sales Models Need to Evolve with the Times
7.9.1 Why are Sales Reps Struggling for Access?
7.9.1.1 One way to Fight Against Reduced Access is to Target the System as a Whole
7.9.1.2 Multichannel Marketing to Overcome Problems of Access
7.9.2 Key Account Management (KAM)
7.9.3 Silos in Sales and Marketing
7.9.4 The Use of KOLs in Pharma Sales
7.10 Market Access
7.10.1 Emerging Stakeholders in Pharma Sales
7.10.2 The Rise of ACOs
7.10.2.1 20% of US Hospitals were Part of an ACO in 2014
7.10.3 Market Access in the EU Over the Next Ten Years
7.10.4 CSOs and Market Access Consulting
7.11 Summary: Main Trends Shaping Pharma Contract Sales 2016-2026
8. Leading Contract Sales Organisations (CSOs)
8.1 Current Industry Landscape
8.2 Quintiles
8.2.1 World Market Leader for Contract Sales and Market Access
8.2.2 New Services and Strategic Partnerships
8.2.3 Quintiles Integrated Health Services Segment Performance 2010-2015
8.2.4 Outlook for Quintiles Contract Sales to 2026
8.3 UDG Healthcare
8.3.1 Global Service Provider with Various Business Units
8.3.2 Geographic and Service Growth Through Acquisitions
8.3.3 Joint Venture with CMIC
8.3.4 UDG Healthcare Financial Performance 2010-2015 and Beyond
8.4 inVentiv Health
8.4.1 Combined CRO and CCO
8.4.2 Global Structure
8.4.3 inVentiv Health Presence in US, EU and Asia
8.4.4 Possible $500m IPO in the Near Future
8.4.5 inVentiv Health Contract Sales Outlook to 2026
8.5 Publicis Healthcare Communications Group
8.5.1 PHCG Purchases PDI Commercial Services Business
8.5.1.1 PDI Prior to Acquisition: Broad Service Portfolio, Resources which PHCG now Acquires
8.5.1.2 PDI Past Financial Performance
8.5.2 Publicis Touchpoint Solutions
8.5.2.1 New Services in Recent Years, and Tardis Medical to be Aligned with the Company
8.6 OnCall, LLC
8.6.1 Range of Services
8.6.2 Contracts with Promius Pharma
8.7 Marvecs
8.7.1 A Local Leader in Germany
8.7.2 New Services Added in Recent Years: Sales 3.0
8.8 Sofip: Contract Sales for the French Submarket
8.9 CMIC
8.9.1 CSO Business in Japan Since 2000
8.10 Leading Players in China are not Just CSOs
9. Research Interviews
9.1 Walter R. Dewees, Executive Vice-President, OnCall LLC
9.1.1 OnCall, LLC
9.1.2 Promotional Outsourcing in the US
9.1.3 Increasing Engagement via Technology-Enabled Multi-Channels
9.1.4 Growing Medical Science Liaison Function
9.1.5 Risk-Sharing Agreement
9.2 Tony Swift, Managing Director, Apodi
9.2.1 Apodi
9.2.2 Market Access Challenges in the UK
9.2.3 CSOs Can Promote Partnership Between Pharma and the NHS
9.2.4 Value Propositions Offered by CSOs
9.3 Holger C.W. Fürstenberg, Founder and Managing Director, Hilver
9.3.1 Hilver
9.3.2 Integrating CLM and Digital Strategy Remains a Challenge
9.3.3 CLM Implementation – Bridging Sales and Marketing
9.3.4 Company Culture is yet to Fully Embrace Digital Toolsets
9.3.5 Digital Tools Facilitate Unparalleled Customer Service
10. Conclusions of the Research and Analysis
10.1 The Global Pharma Contract Sales Market in 2015
10.1.1 Which Sectors Generated the Most Revenues in 2015?
10.1.2 Spending on Contract Sales is Highest in the US and EU
10.2 Outlook for the Pharma Contract Sales Market 2016-2026
10.2.1 Growth Trends for the Leading Submarkets 2016-2026
10.2.1.1 Therapeutic Sector Growth 2016-2026
10.3 Commercial Drivers for Pharma Contract Sales
【レポート販売概要】
■ タイトル：医薬品契約販売の世界市場2016-2026■ 英文：Pharma Contract Sales Market 2016-2026 : Revenue Forecasts for Outsourced Detailing, Including Teledetailing and eDetailing, as well as Medical Education and Sample Management Services
■ 発行日：2016年3月
■ 調査会社：visiongain
■ 商品コード：VGAIN6041537
■ 調査対象地域：グローバル
- 全地形対応車(ATV)用変速機システムの世界市場2019-2023About this market The growing demand for ATVs in APAC will trigger the market’s growth in the forthcoming years. Emerging economies including India and China are witnessing an increase in the demand for ATVs in recent years mainly due to the growing awareness of applications of ATVs among the consumers. In addition, off-road enthusiasts are also increasingly looking for ATVs for engaging in off-ro …
- 世界の玩具及びゲーム市場動向（2014-2018）About Global Toys and Games Toys and games are products used in play, especially by children. They can be used as a tool to help young children learn about life. They can also stimulate physical and mental ability of children. Toys and games includes plush toys, toys for pre-school children, dolls, activity toys such as building sets, and puzzle games such as jigsaw puzzles and card games. TechNav …
- 2014年戦略提言：ヨーロッパの治療薬物モニタリング(TDM)市場This new 291-page report from Venture Planning Group provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Car …
- クラウド実現技術の世界市場：仮想化、オートメーション、サービス指向アーキテクチャ（SOA）About Cloud-enabling Technologies Cloud computing came into existence through advancement in the field of hardware, software, and networking. The evolution of cloud computing is made possible through technologies such as virtualization, automated computing, and service-oriented architecture (SOA). These technologies are commonly termed as cloud-enabling technologies. Cloud computing provides an op …
- Alpha-Pyrrolidoneの世界市場Alpha-Pyrrolidone (CAS 616-45-5) Market Research Report 2013 presents comprehensive data on alpha-pyrrolidone markets globally and regionally (Europe, Asia, North America etc.) The report includes alpha-pyrrolidone description, covers its application areas and related patterns. It overviews alpha-pyrrolidone market, names alpha-pyrrolidone producers and indicates its suppliers. Besides, the report …
- 世界における画像認識ソリューション市場動向(2014-2019)In the era of fast moving technology transitions where visual content is continuously replacing the conventional textual solutions, technologies such as image recognition and 3D object and facial recognition are building a sound foundation for providing top-notch solutions in areas such as infrastructure security and surveillance, automotive safety, automatic driving and parking assistance, forens …
- 自動車用ショックアブソーバーゴムの世界市場ABSTRACTAbout Automotive Shock Absorber Rubber Automotive shock absorber rubber is the rubber that is used for mounting and boot of shock absorbers to protect them from mud, water, pollutants, dust particles, and chipping stones. The raw rubber, which comprises of natural polymer or elastomer, can be divided into two broad categories, namely natural rubber and synthetic rubber. Technavio’s analyst …
- スタンガンの世界市場2017-2021About Stun Guns Stun guns or conducted electrical weapons (CEWs) are used for incapacitating a potential suspect. Such weapons deliver electric shocks with the purpose of disrupting the muscle functions without causing substantial damage to the suspect who could be a threat to law and order. These stun guns are used to control violent situations involving civilians, as well as in scenarios where t …
- ビールの世界市場2016-2020About the Beer Market Beer is the highest consumed alcoholic beverage and the third-most consumed beverage after water and tea in the world. The global beer market is directly proportional to global economic conditions. Beer is also an integral part of the heritage and traditional cuisines of many countries, especially in Europe and the Americas. Technavio’s analysts forecast the global beer marke …
- 世界の総輪駆動自動車及び四輪駆動自動車（AWD＆4WD）市場（2014-2018）TechNavio's analysts forecast the Global All-wheel and 4-wheel Drive Vehicle market to grow at a CAGR of 3.13 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for sports utility vehicles. The Global All-wheel and 4-wheel Drive Vehicle market has also been witnessing the increasing demand for electronically controlled all-wheel an …
- Nidek Co., Ltd.：市場シェア分析Nidek Co., Ltd. Market Share Analysis Summary GlobalData’s new report, “Nidek Co., Ltd. Market Share Analysis” provides in-depth information on Nidek Co., Ltd. .’s market position in the different medical equipment markets it operates in. The report provides Nidek Co., Ltd. . market share information in two key market categories – Ophthalmic Diagnostic Equipment and Refractive Surgery Devices. The …
- ツーリングの世界市場：ダイ＆金型、鍛造、ジグ＆治具、工作機械、ゲージThe global tooling market size is expected to reach $368.5 billion in 2026, from $200.8 billion in 2018, growing at a CAGR of 8.0% from 2019 to 2026. Tooling or tools are a fundamental part of every manufacturing industry. The tooling process includes molding, punching, forging, machining, boring, drilling, and gauging. The instruments required for this purpose include dies & molds and machine too …
- 世界におけるがん免疫療法及びパイプラインインサイトWith more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by almost all the economies of the world. Inspite of the fact that there have been significant improvisation and advancements in surgery, radiation therapy, and chemotherapy over the years, there has hardly been any significant control of this disease by these treatments. There have …
- キシリトールの世界市場2016-2020Technavios research analyst predicts the global xylitol market to grow at a CAGR of around 7% during the forecast period. The global xylitol market is anticipated to grow at a moderate pace owing to the demand for safe, healthy, and economic sugar substitutes. Increasing health concerns regarding lifestyle diseases such as high cholesterol, cardiovascular issues, and obesity has raised consumer aw …
- 世界のキラルクロマトグラフィー・カラム（高速液体クロマトグラフィー用など）市場Over the years, the chiral chromatography columns market has witnessed various technological advancements that have led to an increase in the application areas of chiral chromatography columns. For instance, chiral chromatography columns are widely used in academic research laboratories and a number of industries, including pharmaceutical, biotechnology and biopharmaceutical, food and agriculture, …
